Denali Capital Acquisition (DECA)

Search documents
Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
GlobeNewswire News Room· 2024-06-27 16:30
Group 1 - Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. have mutually agreed to terminate their business combination agreement [1] - The company and its sponsor are looking for alternative ways to complete an initial business combination [1][2] - Denali Capital Acquisition Corp. is a blank check company incorporated in the Cayman Islands, aimed at effecting mergers, share exchanges, asset acquisitions, and similar business combinations [2]
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
GlobeNewswire News Room· 2024-06-11 20:30
Company Overview - Denali Capital Acquisition Corp. is a blank check company incorporated in the Cayman Islands, aimed at executing a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities [3]. Recent Developments - On June 11, 2024, Denali Capital Acquisition Corp. announced the deposit of $50,000 into its trust account to extend the deadline for completing its business combination by one month, from June 11, 2024, to July 11, 2024 [2].
Denali Capital Acquisition (DECA) - 2024 Q1 - Quarterly Report
2024-05-22 00:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) For the quarterly period ended March 31, 2024 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period______ from to______ Commission File No. 001-41351 DENALI CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 98-1659463 (S ...
Denali Capital Acquisition (DECA) - 2023 Q4 - Annual Report
2024-04-01 20:41
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____. Commission File Number: 001-41351 Securities registered pursuant to Section 12(b) of the Act: | | | Name of each exchange on which | | --- | --- | -- ...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
Prnewswire· 2024-03-11 20:30
NEW YORK, March 11, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of $50,000 has been deposited into the Company's trust account to further extend the period of time the Company has to consummate its business combination by an additional month from March 11, 2024 to April 11, 2024 in accordance with the amended terms of the Company's amended and restated memorandum and articles of association. About the Company Denali Capital Acquisiti ...
Denali Capital Acquisition (DECA) - 2023 Q3 - Quarterly Report
2023-11-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period______ from to______ Commission File No. 001-41351 DENALI CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 98-165946 ...
Denali Capital Acquisition (DECA) - 2023 Q2 - Quarterly Report
2023-08-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period______ from to______ Commission File No. 001-41351 DENALI CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 98-1659463 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 437 Madison Avenue, 27th Floor New Yor ...
Denali Capital Acquisition (DECA) - 2023 Q1 - Quarterly Report
2023-05-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period______ from to______ Commission File No. 001-41351 DENALI CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands (State or other j ...
Denali Capital Acquisition (DECA) - 2022 Q4 - Annual Report
2023-03-16 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K For the fiscal year ended December 31, 2022 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____. Commission File Number: 001-41351 Denali Capital Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 98-1659463 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 p ...
Denali Capital Acquisition (DECA) - 2022 Q3 - Quarterly Report
2022-11-15 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------| | | | | I ...